Hypertension
Medicine & Life Sciences
96%
Echocardiography
Medicine & Life Sciences
94%
Atrial Fibrillation
Medicine & Life Sciences
83%
Left Ventricular Dysfunction
Medicine & Life Sciences
66%
Oxidative Stress
Medicine & Life Sciences
62%
Acute Coronary Syndrome
Medicine & Life Sciences
61%
Left Ventricular Hypertrophy
Medicine & Life Sciences
60%
C-Reactive Protein
Medicine & Life Sciences
58%
Hung, C. L. ,
Wu, Y. W. ,
Lin, C. C. ,
Lai, C. H. ,
Juang, J. J. M. ,
Chao, T. H. ,
Kuo, L. ,
Sung, K. T. ,
Wang, C. Y. ,
Wang, C. L. ,
Chu, C. Y. ,
Yu, W. C. &
Hou, C. J. Y. ,
2021 ,
於: Acta Cardiologica Sinica. 37 ,
4 ,
p. 337-354 18 p. 研究成果: Article › 同行評審
Fabry Disease
100%
Galactosidases
55%
Cardiomyopathies
54%
Lysosomal Storage Diseases
25%
Enzyme Replacement Therapy
24%
Anticoagulants
100%
Atrial Fibrillation
96%
Registries
85%
N(4)-oleylcytosine arabinoside
38%
Vitamin K
35%
Lin, C. H. ,
Chen, P. S. ,
Lin, C. C. ,
Chen, Z. C. &
Chang, W. T. ,
2021 ,
於: Acta Cardiologica Sinica. 37 ,
1 ,
p. 108-110 3 p. 研究成果: Letter › 同行評審
Chang, H. Y. ,
Chang, W. T. ,
Chen, P. W. ,
Lin, C. C. &
Hsu, C. H. ,
2020 4月 ,
於: Pulmonary Circulation. 10 ,
2 研究成果: Article › 同行評審
Pulmonary Embolism
100%
Thrombosis
77%
Tomography
68%
Mortality
50%
Computed Tomography Angiography
16%